Methods for producing a complex transgenic trait locus

US10030245B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10030245-B2
Application numberUS-201213427138-A
CountryUS
Kind codeB2
Filing dateMar 22, 2012
Priority dateMar 23, 2011
Publication dateJul 24, 2018
Grant dateJul 24, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for producing in a plant a complex transgenic trait locus comprising at least two altered target sequences in a genomic region of interest are disclosed. The methods involve the use of two or more double-strand-break-inducing agents, each of which can cause a double-strand break in a target sequence in the genomic region of interest which results in an alteration in the target sequence. Also disclosed are complex transgenic trait loci in plants. A complex transgenic trait locus comprises at least two altered target sequences that are genetically linked to a polynucleotide of interest. Plants, plant cells, plant parts, and seeds comprising one or more complex transgenic trait loci are also disclosed.

First claim

Opening claim text (preview).

That which is claimed: 1. A maize plant comprising a complex transgenic trait locus, the trait locus comprising at least first and second altered target sequences, wherein the first altered target sequence originated from a first endogenous target sequence that is recognized and cleaved by a first engineered double-strand-break-inducing agent and the second altered target sequence originated from a second endogenous target sequence that is recognized and cleaved by a second engineered double-strand break-inducing agent, wherein each of said altered target sequences differ from their corresponding endogenous target sequence, wherein the first and second endogenous target sequences are located on the same arm of the same chromosome, wherein each of the alterations comprises a transgene, and wherein at least one of the endogenous target sequences is selected from the group consisting of SEQ ID NOs: 69 and 72. 2. The maize plant of claim 1 , wherein the transgene is selected from the group consisting of DNA for gene silencing, DNA encoding a phenotypic marker and DNA encoding a protein providing an agronomic advantage. 3. A seed of the maize plant of claim 1 , comprising said complex transgenic trait locus.

Assignees

Inventors

Classifications

  • Targeted insertion of genes into the plant genome by homologous recombination · CPC title

  • A01H1/06Primary

    Processes for producing mutations, e.g. treatment with chemicals or with radiation (specific mutations prepared by genetic engineering on plant cell or plant tissues C12N15/00 {; process for producing transgenic plants C12N15/82}) · CPC title

  • by biological means, e.g. cell mediated or natural vector · CPC title

  • Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

  • Genetically Modified [GMO] plants, e.g. transgenic plants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10030245B2 cover?
Methods for producing in a plant a complex transgenic trait locus comprising at least two altered target sequences in a genomic region of interest are disclosed. The methods involve the use of two or more double-strand-break-inducing agents, each of which can cause a double-strand break in a target sequence in the genomic region of interest which results in an alteration in the target sequence.…
Who is the assignee on this patent?
Lassner Michael, Jantz Derek, Smith James Jefferson, and 8 more
What technology area does this patent fall under?
Primary CPC classification A01H1/06. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).